Add Company
Join Now

MyMD Pharmaceuticals Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • MyMD Pharmaceuticals's estimated annual revenue is currently $2.6M per year.(i)
  • MyMD Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • MyMD Pharmaceuticals has 13 Employees.(i)
  • MyMD Pharmaceuticals grew their employee count by 0% last year.

MyMD Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.2M31-11%N/AN/A
#2
$2.6M130%N/AN/A
#3
$6.8M34-6%N/AN/A
#4
$5.8M29-44%N/AN/A
#5
$405.4M201718%N/AN/A
#6
$29.9M1499%N/AN/A
#7
$127.4M63419%N/AN/A
#8
$15.5M7726%N/AN/A
#9
$35.2M1754%N/AN/A
#10
$30.4M151-3%N/AN/A
Add Company

What Is MyMD Pharmaceuticals?

MyMD is a clinical stage biotech pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immunometabolic system to control tumor necrosis factor alpha (TNF-α) and other pro-inflammatory cytokines. MYMD-1 is being developed to treat autoimmune diseases, including those currently treated with non-selective TNF-α blocking drugs, and aging and longevity. Supera-CBD is a drug platform based on a novel (patent pending) synthetic derivative of cannabidiol (CBD) that targets numerous key receptors including CB2 and opioid receptors and inhibits monoamine oxidase. Supera-CBD is being developed to address the rapidly growing CBD market that includes FDA approved drugs and CBD products not currently regulated as a drug.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.1M138%N/A
#2
$2.1M138%N/A
#3
$3.3M13-19%N/A
#4
$2M1386%N/A
#5
$1.8M130%N/A